Sema4 Stock

sema4.comHealthcare / Healthcare providers & servicesFounded: 2015Funding to Date: $368.26MM

Sema4 is the developer of an AI-driven patient-centered genomic and clinical data insight platform designed to to transform healthcare by building dynamic models of human health and defining optimal, individualized health trajectories, starting in the areas of reproductive health and oncology.

Register for Details

For more details on financing and valuation for Sema4, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Sema4.

Register Today

Other companies like Sema4 in the Healthcare providers & services sector

Sector
Last Round Est. Valuation
$648.94MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$1.39B
Sector
Last Round Est. Valuation
$5.7B
Sector
Last Round Est. Valuation
$37.8MM
Sector
Last Round Est. Valuation
$1.81B
Sector
Last Round Est. Valuation
$2.18B
Sector
Last Round Est. Valuation
$3.52B
Sector
Last Round Est. Valuation
$1.53B

News Highlights

Sema4 to Study Precision Oncology Disparities in Nationwide Biobanking, Genomic Profiling Study
The firm will use its suite of assays to characterize samples from 5,000 advanced cancer patients from underserved communities and create a representative biobank.
Sema4 Q4 Revenues Decline 10 Percent
Sema4 beat the consensus Wall Street estimate on the top and bottom lines for Q4 and said it expects between $215 million and $225 million in revenues for 2022.
Updated on: Sep 21, 2023